Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

EAST CAROLINA HEALTH-BERTIE

NPI: 1013999705 · WINDSOR, NC 27983 · Critical Access Hospital

$5.47M
Total Medicaid Paid
63,648
Total Claims
59,417
Beneficiaries
60
Codes Billed
2018-01
First Month
2024-12
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 10,232 $746K
2019 7,565 $715K
2020 3,696 $296K
2021 7,712 $647K
2022 9,789 $937K
2023 11,728 $1.08M
2024 12,926 $1.05M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 12,734 12,168 $2.28M
99284 5,400 5,136 $1.29M
99285 1,669 1,564 $369K
0241U 2,371 2,270 $336K
99282 1,363 1,310 $208K
93005 2,839 2,675 $169K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 4,327 3,610 $117K
96375 999 910 $106K
71045 1,415 1,336 $102K
96374 1,309 1,232 $85K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2,685 2,568 $64K
70450 125 121 $47K
85025 7,723 7,119 $45K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 435 419 $36K
74177 41 36 $27K
71046 214 207 $24K
80053 3,435 3,198 $22K
J3490 Unclassified drugs 861 682 $20K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 129 110 $17K
80048 2,290 2,148 $15K
94640 132 126 $10K
96372 221 209 $9K
87804 367 358 $8K
84484 1,209 1,125 $8K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 277 271 $7K
81001 1,909 1,829 $5K
80307 83 81 $5K
J7030 Infusion, normal saline solution , 1000 cc 450 396 $5K
96361 172 156 $4K
83735 957 878 $4K
83690 535 503 $3K
36415 1,799 1,701 $3K
96365 43 38 $2K
81025 240 226 $2K
81003 732 692 $2K
99199 271 271 $2K
85027 323 306 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg 324 288 $1K
84443 99 97 $1K
83605 157 147 $1K
87088 94 88 $782.08
J2270 Injection, morphine sulfate, up to 10 mg 142 117 $670.62
J1885 Injection, ketorolac tromethamine, per 15 mg 86 81 $649.46
82248 120 110 $568.08
83036 74 72 $566.95
80061 26 25 $277.86
87086 43 43 $271.35
87070 29 27 $257.52
87635 13 13 $256.55
11720 12 12 $200.05
87430 14 14 $199.92
G0127 Trimming of dystrophic nails, any number 25 25 $192.92
82077 61 60 $176.40
87040 25 24 $172.39
J1100 Injection, dexamethasone sodium phosphate, 1 mg 13 13 $118.53
87807 13 13 $99.96
82962 62 52 $97.80
J1200 Injection, diphenhydramine hcl, up to 50 mg 13 13 $75.74
S0028 Injection, famotidine, 20 mg 12 12 $66.51
G1010 Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program 107 86 $14.00